~~<i id='663A0B61D2'><strike id='663A0B61D2'><tt id='663A0B61D2'><pre id='663A0B61D2'></pre></tt></strike></i>~~

00:00

00:00 00:00 LIVE

buffering

Replay

Wikipedia

knowledge

author：Wikipedia 2025-10-02 19:19:43 - browse：4

A European regulatory panel has recommended against approval of a lung cancer drug made by Mirati Therapeutics, the company said Friday.

Mirati said it will appeal the negative opinion of the drug, called Krazati, issued by a committee of the European Medicines Agency that met this week. But for now, the adverse decision is likely to be adopted by European regulators and prevent the company from marketing the pill in Europe.

Krazati works by blocking a specific type of KRAS alteration called G12C, found in approximately 13% of lung tumors.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Bright Health sells Medicare Advantage business to Molina
Next article： Police still searching for prisoner who escaped from NYC hospital

knowledge

focus

Wikipedia

entertainment

explore

RobertKennedy,Jr.toldTheNewYorkTimesawormdiedinhisbrainandcausedneurologicalsymptoms.JOSHEDELSON/AFP

WSS

Steward Health Care files for bankruptcy

FDA panel issues narrow recommendation for Covid vaccine booster doses

Man killed during FBI raid in connection with threats against Biden, other officials

FDA panel issues narrow recommendation for Covid vaccine booster doses

Man killed during FBI raid in connection with threats against Biden, other officials

Telehealth startups turn to complex chronic diseases

Wikipedia

knowledge

knowledge

The cancer drug shortage isn’t new — and neither are the solutions

Shionogi licenses Pompe disease therapy from Maze Therapeutics

Duchenne breakthrough therapy leaves behind pioneering families

Steward Health Care files for bankruptcy

Apple is now the first public company to be valued at $3 trillion

Readout LOUD podcast: What to know about H5N1 bird flu

Malaria cases in Florida and Texas: Here’s what you need to know

The best solution to the drug shortages problem

Cancer drug shortages should be causing more outrage

It shouldn't be easy to buy synthetic DNA to recreate a deadly virus

focus

Readout LOUD podcast: brain research, obesity drug sales, Novartis

Software glitch causes Tandem insulin pump to shutdown, FDA warns

Study: Adult vaccinations pay for themselves in societal benefits

Telehealth startups turn to complex chronic diseases

Friends ask where James Watson's attitudes about race came from

Naloxone nonprofit donates 200,000 doses after FDA approval

Wikipedia

Wikipedia

entertainment

explore